Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Application of FSME-Immun in allergic patients
2012-005672-34Phase 4Completed
- Sponsor
- Institute of Specific Prophylaxis and Tropical Medicine
- Start
- Jan 2013
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Institute of Specific Prophylaxis and Tropical Medicine. Started Jan 2013; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2012-005672-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005672-34.